[Use of no-protein blood extract for infertility and sterility (author's transl)]

[Use of no-protein blood extract for infertility and sterility (author's transl)] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Use of no-protein blood extract for infertility and sterility (author's transl)] Abstract Text:

R Hofmann,H Heise,A Mattheus,

In vitro studies into the effects of various concentrations of Solcoseryl (Solco, Basle, Switzerland) on selected asthenozoospermia patients have shown rise in motility in 26 per cent of the probands and decline in motility in 17 per cent. Spermatozoan motility was most strongly increased by a five per cent concentration of Solcoseryl.--Fifty-one patients, from whom different spermiographic findings had been earlier obtained, received ten injections of one ampoule of Solcoseryl daily, with weekend pauses inserted. Included were 46 oligozoospermia, 31 asthenozoospermia, and eight hypospermia. Spermiographic checks were undertaken on termination of therapy, and others followed two weeks, four weeks, three months, and six months after termination of therapy. They all gave improved findings, which were most unambiguous with regard to the number of spermia.--Findings were at least temporarily normal after treatment in 58 per cent of the patients with asthenozoospermia. The wives of eleven in 44 patients (25 per cent) with Solcoseryl treatment were pregnant after three months, as established in follow-up examinations. Artificial insemination was applied to 45 patients, among them 37 with maritogenic approach and eight cases with donogenic approach, using Solcoseryl. Eleven pregnancies were obtained from maritogenic insemination. Pregnancy was achieved in 38 per cent of the probands who received cryopreserved donor semen. These findings would not justify the claim of direct conception-producing action for Solcoseryl, in the context of insemination treatment.

[Use of no-protein blood extract for infertility and sterility (author's transl)] Publishing Authors By Initials

R Hofmann,H Heise,A Mattheus,

For similar complex mixtures: tissue extracts research abstracts see: complex mixtures: tissue extracts research

PUBMED ID PMID:

MEDLINE DATE:

[Use of no-protein blood extract for infertility and sterility (author's transl)] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Zentralblatt für Gynäkologie

VOLUME: 103

Page Numbers: 1147-54

Journal Abbreviation: Zentralbl Gynakol

ISSN: 0044-4197

DAY: 11

MONTH: 02

YEAR: 1981

[Use of no-protein blood extract for infertility and sterility (author's transl)] Information

Number of References:

LANGUAGE: ger

NlmUniqueID: 21820100

[Use of no-protein blood extract for infertility and sterility (author's transl)] Keywords Mesh Terms:

KEYWORDS: Tissue Extracts

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: [Use of no-protein blood extract for infertility and sterility (author's transl)] Information

Substance Name: Actihaemyl

Registry Number: 37239-28-4

Grant and Affiliation Information for [Use of no-protein blood extract for infertility and sterility (author's transl)]

AFFILIATION:

Country: GERMANY, EAST

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Zentralbl Gynakol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Use of no-protein blood extract for infertility and sterility author's transl Related Publications

• [Practical significance of umbilical cord complications for the management of delivery]
• [Use of no-protein blood extract for infertility and sterility (author's transl)]